SCHEMBL14867262

SCHEMBL14867262

Cc1ccc(-c2[nH]c(=O)c3cc(C)ccc3c2N(C)C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.44
HPGD P15428 5/20 0.44
ALDH1A1 P00352 4/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
LMNA P02545 2/20 0.44
RAB9A P51151 2/20 0.44
NPC1 O15118 2/20 0.44
MAPK1 P28482 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
PBK Q96KB5 4/20 0.40
HSD17B10 Q99714 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
GAA P10253 1/20 0.39
PARP1 P09874 2/20 0.38
GFER P55789 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14867284 0.86 KDM4E (0.51) KDM4EHPGDALDH1A1MEN1KMT2A
SCHEMBL14867316 0.80 SERPINE1 (0.53) KDM4EHPGDALDH1A1MEN1KMT2A
SCHEMBL14867256 0.80 KDM4E (0.44) KDM4EHPGDALDH1A1MEN1KMT2A
SCHEMBL12324330 0.78 KDM4E (0.48) KDM4EHPGDALDH1A1MEN1KMT2A
SCHEMBL14867254 0.78 PARP1 (0.46) KDM4EHPGDALDH1A1MEN1KMT2A
SCHEMBL14867276 0.78 KDM4E (0.43) KDM4EHPGDALDH1A1MEN1KMT2A
SCHEMBL14867264 0.78 MAOA (0.48) KDM4EHPGDALDH1A1MEN1KMT2A
SCHEMBL14867269 0.76 ALB (0.41) KDM4EHPGDALDH1A1MEN1KMT2A
SCHEMBL14867277 0.74 ALDH1A1 (0.41) KDM4EHPGDALDH1A1MEN1KMT2A
SCHEMBL14867251 0.74 HPRT1 (0.41) KDM4EHPGDALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8883763-B2 Use of isoquinolones for preparing drugs, novel isoquinolones and method for synthesising same UNIVERSITE JOSEPH FOURIER (FR) 2014-11-11 US disclosed
US-20130096083-A1 USE OF ISOQUINOLONES FOR PREPARING DRUGS, NOVEL ISOQUINOLONES AND METHOD FOR SYNTHESISING SAME UNIVERSITE JOSEPH FOURIER (FR) 2013-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130096083-A1 USE OF ISOQUINOLONES FOR PREPARING DRUGS, NOVEL ISOQUINOLONES AND METHOD FOR SYNTHESISING SAME GNAQ, HCCS, SDHA KDM4E 1796/4885HPGD 61/4885ALDH1A1 2507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.